204 search results
- Current search:
- Dementia and Cognitive Improvement
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
UpdatedCochrane EvidencePublished 15 Jun 2017
Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
Background Dementia is a global healthcare concern. Type 2 diabetes mellitus — a form of diabetes which becomes commoner with older age — increases the risk of developing dementia. Type 1 diabetes, which typically begins earlier in life, is always treated with insulin; but there are a variety of different ways of treating Type 2 diabetes, including ... -
NewCochrane EvidencePublished 11 Jun 2017
Assistive technology for memory support in dementia
Review question We wanted to find out from a review of the evidence whether Assistive Technology can help people with dementia overcome some of the effects of their memory problems. Background Dementia causes memory problems that make it increasingly difficult to carry out everyday activities, for example cooking, remembering appointments, taking ... -
Cochrane EvidencePublished 22 May 2017
Benzodiazepines for treatment of delirium in non-ICU settings
Protocol: To determine the effectiveness and safety of benzodiazepines in the treatment of delirium (excluding delirium related to alcohol or benzodiazepines withdrawal) in all settings other than intensive care units (ICUs). -
Cochrane EvidencePublished 2 May 2017
Music-based therapeutic interventions for people with dementia
Background People with dementia gradually develop difficulties with memory, thinking, language and daily activities. Dementia is often associated with emotional and behavioural problems and may lead to a reduction in a person's quality of life. In the later stages of dementia it may be difficult for people to communicate with words, but even when ... -
TitlePublished 30 Apr 2017
Cannabinoids for the treatment of dementia
Dementia and Cognitive Improvement Group Livia Puljak Title Monday, April 24, 2017 ... -
Cochrane EvidencePublished 18 Apr 2017
Simulated presence therapy for dementia
Review question Can simulated presence therapy (SPT) treat problem behaviours, and improve quality of life for people with dementia? Background Dementia is an illness, most common among older people, in which memory and other brain functions deteriorate and people gradually become dependent on others for care. Many people with dementia, particularly ... -
Cochrane EvidencePublished 18 Apr 2017
The use of vitamin E in the treatment of mild cognitive impairment and Alzheimer's disease (AD)
Background Vitamin E is found in a variety of foods, including vegetable oils and fats, nuts and seeds. Some animal and non-interventional studies have suggested it might have a role in the prevention or treatment of Alzheimer's disease (AD). However, evidence has linked vitamin E with potentially serious side effects and even an increased risk of ... -
Cochrane EvidencePublished 10 Apr 2017
Non-pharmacological interventions for managing delirium in hospitalised patients
Protocol: To determine the effectiveness of single or multicomponent non-pharmacological interventions in reducing the symptoms, duration or severity of an established episode of delirium in hospitalised people outside intensive care settings. -
TitlePublished 16 Jul 2017
Mindfulness-based stress reduction for family caregivers of people with dementia
Dementia and Cognitive Improvement Group Zheng Liu Title Thursday, March 23, 2017 ... -
Cochrane EvidencePublished 26 Mar 2017
L-carnitine for cognitive enhancement in people without cognitive impairment
Background Cognition (or cognitive function) is a term used to describe thinking skills, including attention, memory, and reasoning. Supplements and drugs are sometimes used by healthy people to try to improve cognitive function and perform better at work or while studying. These supplements and drugs are known as cognitive enhancers. L-carnitine, ...
